Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
882.5 USD | -0.92% | -1.59% | +0.49% |
06:25pm | Regeneron Faces Q1 Seasonality Despite Eylea HD Launch, Oppenheimer Says | MT |
02:45pm | Oppenheimer Adjusts Price Target on Regeneron Pharmaceuticals to $1,175 From $1,125 | MT |
- Stock Market
- Equities
- REGN Stock
- News Regeneron Pharmaceuticals, Inc.